DOST approves VCO trial for COVID-19 at PGH
The Department of Science and Technology (DOST) has approved clinical trials for virgin coconut oil (VCO) at the Philippine General Hospital (PGH) involving 100 patients.
Half of the patients will receive VCO while the other half will not, to compare its effects on COVID-19.
DOST is also negotiating vaccine trials with institutions from China and Taiwan.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.